Ausgabe 2/2024
Inhalt (9 Artikel)
Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy
Kerstin Michalski, Aleksander Kosmala, Rudolf A. Werner, Sebastian E. Serfling, Anna K. Seitz, Constantin Lapa, Andreas K. Buck, Philipp E. Hartrampf
Difference in arterial FDG accumulation in healthy study participants between digital PET/CT and standard PET/CT
Noriko Nitta, Rika Yoshimatsu, Hitomi Iwasa, Kousuke Nakaji, Kana Miyatake, Miki Nishimori, Tomohiro Matsumoto, Tomoaki Yamanishi, Takuji Yamagami
A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy
Shamim Ahmed Shamim, Naresh Kumar, Geetanjali Arora, Sahil Jaswal, Shalimar, Shivanand Gamanagatti, Chandrasekhar Bal
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography
Akira Makino, Kyo Kume, Tetsuya Mori, Tetsuya Tsujikawa, Tatsuya Asai, Hidehiko Okazawa, Yasushi Kiyono
[18F]-FDG uptake in brain slices prepared from an aged mouse model of Alzheimer’s disease using a dynamic autoradiography technique
Hiroko Maruyama, Misaki Gomi, Thet-Thet Lwin, Akio Yoneyama, Toru Sasaki
Comparative study of physiological FDG uptake in small structures between silicon photomultiplier-based PET and conventional PET
Shiro Watanabe, Kenji Hirata, Keiichi Magota, Junki Takenaka, Naoto Wakabayashi, Daiki Shinyama, Koichi Yasuda, Akihiro Homma, Kohsuke Kudo
99mTc(CO)3-labeled 1-(2-Pyridyl)piperazine derivatives as radioligands for 5-HT7 receptors
Alireza Mardanshahi, Samaneh Vaseghi, Seyed Jalal Hosseinimehr, Seyed Mohammad Abedi, Sajjad Molavipordanjani
Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner
Yuki Shinohara, Masanobu Ibaraki, Keisuke Matsubara, Kaoru Sato, Hiroyuki Yamamoto, Toshibumi Kinoshita